Investigating the role of a specific molecule in the development of eye disease that causes blindness.
Role of Bruch Membrane Heparan Sulfate in Drusenogenesis in Age-Related Macular Degeneration
This study is looking at how a molecule in the eye called heparan sulfate might play a role in the buildup of drusen, which can lead to age-related macular degeneration (AMD), a common cause of vision loss in older adults, with the hope of finding new ways to help treat this condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10886293 on NIH RePORTER |
What this research studies
This research focuses on understanding how heparan sulfate, a type of molecule found in the eye, contributes to the formation of drusen, which are deposits that can lead to age-related macular degeneration (AMD). AMD is a major cause of vision loss, particularly in older adults, and currently has no effective treatments for its early stages. The study will explore the changes in heparan sulfate in the Bruch membrane of the eye as people age and how these changes may influence the development of drusen. By uncovering the mechanisms behind drusen formation, the research aims to provide insights that could lead to new therapeutic strategies for AMD.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who are at risk for or have early to intermediate stages of age-related macular degeneration.
Not a fit: Patients with advanced age-related macular degeneration or other unrelated eye conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for age-related macular degeneration, potentially preserving vision for millions of patients.
How similar studies have performed: Other research has shown promising results in understanding the role of molecular changes in eye diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Toomey, Christopher B — University of California, San Diego
- Study coordinator: Toomey, Christopher B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.